Monica M. Reinholz

<i>HER2</i> and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial

Edith A. Perez, Monica M. Reinholz, David W. Hillman et al. · Journal of Clinical Oncology · 2010 · 237 citations · Full text

Medicine, Oncology, Pharmacology +17

Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial

Edith A. Perez, E. Aubrey Thompson, Karla V. Ballman et al. · Journal of Clinical Oncology · 2015 · 205 citations · Full text

Medicine, Immunology, Oncology +17

Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the North Central Cancer Treatment Group N9831 Trial

Edith A. Perez, Amylou C. Dueck, Ann E. McCullough et al. · Journal of Clinical Oncology · 2013 · 107 citations · Full text

Medicine, Molecular Biology, Oncology +17

Differential Gene Expression of TGF-β Family Members and Osteopontin in Breast Tumor Tissue: Analysis by Real-Time Quantitative PCR

Monica M. Reinholz, Stephen J. Iturria, James N. Ingle et al. · Breast Cancer Research and Treatment · 2002 · 87 citations

Life Sciences, Cancer Biology, Molecular Biology +11

Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast Cancer

Monica M. Reinholz, Andrea M. Nibbe, Leslie M. Jonart et al. · Clinical Cancer Research · 2005 · 82 citations · Full text

Medicine, Molecular Medicine, Oncology +17